Journal article
Guidelines on the Use of Intravenous Immune Globulin for Hematologic Conditions
Abstract
Canada's per capita use of intravenous immune globulin (IVIG) grew by approximately 115% between 1998 and 2006, making Canada one of the world's highest per capita users of IVIG. It is believed that most of this growth is attributable to off-label usage. To help ensure IVIG use is in keeping with an evidence-based approach to the practice of medicine, the National Advisory Committee on Blood and Blood Products of Canada (NAC) and Canadian Blood …
Authors
Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R
Journal
Transfusion Medicine Reviews, Vol. 21, No. 2 Suppl 1, pp. s9–s56
Publisher
Elsevier
Publication Date
April 2007
DOI
10.1016/j.tmrv.2007.01.001
ISSN
0887-7963